Chris Schelling
Overview
Chris Schelling received an average of $777K in total compensation, including $387K in salary, at Opexa Therapeutics from 2017 to 2022.
2022Opexa TherapeuticsPresident and Chief Executive Officer
2021Opexa TherapeuticsPresident and Chief Executive Officer
2020Opexa TherapeuticsPresident and Chief Executive Officer
2019Opexa TherapeuticsPresident and Chief Executive Officer
2018Opexa TherapeuticsPresident and Chief Executive Officer
2017Opexa TherapeuticsPresident and Chief Executive Officer
Source: SEC filings on April 14, 2023, April 15, 2022, April 16, 2021, October 14, 2020, April 12, 2019, and April 9, 2018.
Related executives
We found 14 more executives who work or worked at Opexa Therapeutics.
Adrian Quartel
Opexa Therapeutics
Chief Medical Officer
Harry Palmin
Opexa Therapeutics
Chief Financial Officer
Jefferson Davis
Opexa Therapeutics
Chief Business Officer
Donald Joseph
Opexa Therapeutics
Chief Legal Officer
William FACP
Opexa Therapeutics
Chief Medical Officer
Neil Warma
Opexa Therapeutics
Chief Executive Officer
William Andrews
Opexa Therapeutics
Chief Medical Officer
Don Healey
Opexa Therapeutics
Chief Scientific Officer
News
Opexa Therapeutics CEO Chris Schelling's 2022 pay jumps 51% to $834K
April 14, 2023
Opexa Therapeutics Chief Business Officer Jefferson Davis receives $635K in 2021
April 15, 2022
Opexa Therapeutics CEO Chris Schelling's 2020 pay falls 54% to $676K
April 16, 2021
Opexa Therapeutics CEO Chris Schelling's 2019 pay jumps 167% to $1.5M
October 14, 2020
Opexa Therapeutics CEO Chris Schelling's 2018 pay slips 6% to $550K
April 12, 2019